This function of OPTN is inhibited by the ALS-associated mutation, E478G, which has deficient ubiquitin-binding abilities, and also by F178A, which has impaired LC3 recruitment (Wong and Holzbaur, 2015). The gene discussed is MAP1LC3A; the disease is amyotrophic lateral sclerosis.